Oral Cannabis Spray Sativex to Be Tested on Dementia Patients in Major Trial

This fall, researchers at King’s College in London will begin a test of medical marijuana on patients with dementia to determine whether the drug will help treat symptoms like agitation and aggression. The team will use Sativex, an oral spray that contains THC and CBD. Lead researcher Chris Albertyn said they hope the drug can be used as an alternative to antipsychotic medications that are used to treat aggression in those with dementia, but often come with dangerous side effects. Previously, Sativex was approved to treat patients with multiple sclerosis (MS) and alleviate joint pain. Albertyn said that though the trial is currently aimed at UK residents, the researchers hope to conduct multinational studies testing Sativex on dementia patients if the results of the pilot study seem promising. Read more here. 

Leave a Comment

Get one-month FREE access to our online yoga membership site.

Sign up to our mailing list to get one month free (Value $97)

We guard your privacy and will not sell/share your personal information.
We will contact you with information related of things of interest on an occasional basis.
To read our Privacy Policy Click here